Successful treatment of cholinergic urticaria with anti-immunoglobulin E therapy.
Metz
M
M
Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Charitéplatz, Berlin, Germany.
Bergmann
P
P
Zuberbier
T
T
Maurer
M
M
D000328:Adult; D018926:Anti-Allergic Agents / Q000627:therapeutic use*; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal / Q000378:metabolism / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D002908:Chronic Disease; D006801:Humans; D007073:Immunoglobulin E / Q000378:metabolism; D008297:Male; D000069444:Omalizumab; D016896:Treatment Outcome; D014581:Urticaria / Q000188:drug therapy* / Q000276:immunology
D018926:Anti-Allergic Agents; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069444:Omalizumab; D007073:Immunoglobulin E